21 December 2022
SHARE NOW
ATW
Cell Therapy
Partnering
Raw Materials
In this interview, Brandon McNaughton, CEO and Co-Founder of Akadeum Life Sciences, explains the story of innovation for the application of microbubbles in cell therapy manufacturing, and the impact innovation can have on the future of healthcare.
Through explaining the story behind Akadeum and the application of innovative technologies, Brandon discusses the process of overcoming limitations and challenges associated with downstream cell therapy manufacturing.
Brandon goes on to discuss the process of deployment through collaboration, before explaining what it is companies like Akadeum look for in a partner, and what to look out from Akadeum over the next few months.
If you are joining us at Advanced Therapies Week 2023, make sure to visit Akadeum as the team previews their new automated instrument! Not yet registered? Get your tickets here >>
This interview has been produced in partnership with Akadeum Life Sciences, ahead of Advanced Therapies Week 2023.
 |
 |
More like this
ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies
We caught up with Patrick M Gailliot, Sr. Director, Patient Operations at Abeona Therapeutics, to talk to him about why his work gives him so much joy, preview his session at Advanced Therapies Week in Dallas, and explain the value he gets from the event.
26 November 2024
Texas Cell and Gene Manufacturing Landscape
Ahead of Advanced Therapies Week 2025 in Dallas, we take a look at the Texas cell and gene manufacturing landscape.
19 November 2024
Full Agenda Released for Advanced Therapies Week 2025 in Dallas
Phacilitate Unveils Full Agenda for Advanced Therapies Week 2025, Bringing Together Leaders to Shape the Future of Healthcare
12 November 2024
